Answers are grounded in this paper and cite their sources.
Systematic review and meta-analysis reveals intensive blood pressure control does not improve outcomes in chronic kidney disease patients, indicating a need for further studies.
Background: Optimal blood pressure (BP) targets in patients with chronic kidney disease (CKD) stage 3 or higher remain controversial, with uncertainty about whether intensive BP control improves outcomes compared to standard control. Summary: This systematic review and meta-analysis included 11 randomized controlled trials (RCTs) with 8,740 participants, comparing intensive versus standard BP targets in CKD stage 3+ patients. Meta-analysis using a random-effects model showed no significant reduction in all-cause mortality with intensive control (RR 0.91, 95% CI 0.73–1.13). Similarly, there were no significant differences in other outcomes. Key Messages: Intensive BP control did not improve overall mortality or renal outcomes in CKD patients. Further large, long-term studies are warranted.
No takes yet. Share an insight, caveat, or question.
Fallahtafti et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: